IDVO - ETF AI Analysis
Top Page
Amplify International Enhanced Dividend Income ETF (IDVO)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains over the past month, three months, and year-to-date, indicating solid recent momentum.
Healthy Top Holdings
Most of the largest positions, including major financial, technology, and healthcare names, have delivered positive year-to-date performance that supports the fund.
Broad Sector Diversification
Holdings spread across financials, materials, industrials, technology, energy, healthcare, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can modestly reduce net returns over time.
Heavy U.S. Exposure
Despite being an international-focused strategy, the portfolio is heavily tilted toward U.S. securities, limiting the benefits of global diversification.
Mixed Performance Among Top Holdings
While most top holdings are performing well, at least one significant position has been weak year-to-date, which can drag on overall results if that continues.
IDVO vs. SPDR S&P 500 ETF (SPY)
AUM1.08B
RegionGlobal Ex-U.S.
Expense Ratio0.65%
Beta0.78
IssuerAmplify
Inception DateSep 08, 2022
Dividend Yield5.29%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume234,120
30 Day Avg. Volume446,358
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
45.51Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering55
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IDVO Summary
The Amplify International Enhanced Dividend Income ETF (IDVO) is an actively managed fund (no fixed index) that focuses on international companies paying attractive dividends. It holds a mix of sectors like financials, materials, and technology, with major positions in well-known names such as Alibaba, TSMC, Novartis, and AstraZeneca. Investors might consider IDVO to seek regular income from dividends while adding global diversification beyond the U.S. market. However, the fund’s value and income can go up and down with international markets and currency movements, and it is fairly concentrated in financial stocks.
How much will it cost me?The Amplify International Enhanced Dividend Income ETF (IDVO) has an expense ratio of 0.66%, which means you’ll pay $6.60 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on enhancing dividend income through a diversified global portfolio.
What would affect this ETF?The Amplify International Enhanced Dividend Income ETF (IDVO) could benefit from global economic growth, particularly in sectors like technology and financials, which are heavily weighted in its portfolio. However, it may face challenges from rising interest rates, which could impact dividend-paying stocks, and geopolitical tensions or regulatory changes in the international markets where it operates. Diversification across sectors and regions provides some resilience, but exposure to specific companies like Alibaba and TSMC means performance could be influenced by trends in e-commerce and semiconductor industries.
IDVO Top 10 Holdings
IDVO leans heavily on international financials and resource names, with a clear tilt toward non-U.S. markets. Eni has been the star of the show lately, powering ahead and giving the fund a nice energy tailwind, while Nutrien adds steady strength from the materials side. TSM and Cameco are more mixed—long-term stories that have helped over the past few months but recently lost a bit of momentum. On the downside, Alibaba has been dragging the fund, as sentiment around Chinese tech remains shaky and keeps this holding under pressure.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 4.17% | $43.31M | $1.59T | 130.49% | 81 Outperform | |
| Nutrien | 3.69% | $38.41M | $36.02B | 54.68% | 75 Outperform | |
| Bank Of Montreal | 3.11% | $32.38M | C$137.74B | 53.73% | 74 Outperform | |
| Mitsubishi UFJ | 2.88% | $29.96M | $203.21B | 55.66% | 77 Outperform | |
| Cameco | 2.87% | $29.82M | C$69.90B | 189.39% | 71 Outperform | |
| Alibaba | 2.77% | $28.85M | $272.25B | 19.60% | 68 Neutral | |
| America Movil | 2.58% | $26.83M | $80.31B | 87.78% | 60 Neutral | |
| AstraZeneca | 2.58% | $26.81M | $316.10B | 57.40% | 80 Outperform | |
| Sumitomo Mitsui | 2.57% | $26.73M | $135.14B | 60.09% | 76 Outperform | |
| Agnico Eagle | 2.53% | $26.29M | $107.68B | 103.77% | 80 Outperform |
IDVO Technical Analysis
Positive
―
Price Trends
41.25
Positive
39.77
Positive
37.22
Positive
Market Momentum
0.19
Negative
63.41
Neutral
93.80
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDVO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 40.20, equal to the 50-day MA of 41.25, and equal to the 200-day MA of 37.22, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 63.41 is Neutral, neither overbought nor oversold. The STOCH value of 93.80 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IDVO.
IDVO Peer Comparison
Comparison Results
Performance Comparison
IDVO
Amplify International Enhanced Dividend Income ETF
42.33
14.89
54.26%
ILOW
AB International Low Volatility Equity ETF
―
―
―
CGIC
Capital Group International Core Equity ETF
―
―
―
WCMI
First Trust WCM International Equity ETF
―
―
―
APIE
ActivePassive International Equity ETF
―
―
―
MFSI
MFS Active International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents